Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
André PfobChris Chris Sidey-GibbonsGeraldine RauchBettina ThomasBenedikt SchaefgenSherko KuemmelToralf ReimerMarkus HahnMarc ThillJens-Uwe BlohmerJohn HackmannWolfram MalterInga BekesKay FriedrichsSebastian WojcinskiSylvie JoosStefan PaepkeTom DegenhardtJoachim RomAchim RodyMarion T van MackelenberghMaggie Banys-PaluchowskiRegina GroßeMattea ReinischMaria KarstenMichael GolattaJoerg HeilPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
An intelligent VAB algorithm can reliably exclude residual cancer after NST. The omission of breast and axillary surgery for these exceptional responders may be evaluated in future trials.
Keyphrases
- lymph node
- neoadjuvant chemotherapy
- minimally invasive
- coronary artery bypass
- ultrasound guided
- locally advanced
- sentinel lymph node
- rectal cancer
- surgical site infection
- papillary thyroid
- machine learning
- squamous cell carcinoma
- deep learning
- fine needle aspiration
- current status
- radiation therapy
- lymph node metastasis